pharmaceutical investing scPharmaceuticals Receives Complete Response Letter from the FDA for FUROSCIX
Premier American Uranium Reports Results Following Annual General and Special Meeting of Shareholders
Nuvau Winter Drilling at Thundermine Returns 5.28 g/t Au over 6.1 m, Including 7.22 g/t Au over 3.1 m
